H.R. 7693 (119th)Policy Lenses

To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.

Health|Health
Cosponsors
Support
Bipartisan
Introduced
Feb 25, 2026
Discussions
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Loading policy lenses…